Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD

Chronic obstructive pulmonary disease (COPD) treatment guidelines do not currently include recommendations for escalation directly from monotherapy to triple therapy. This 12-week, double-blind, double-dummy study randomized 800 symptomatic moderate-to-very-severe COPD patients receiving tiotropium...

Descripción completa

Detalles Bibliográficos
Autores principales: Bansal, Sandeep, Anderson, Martin, Anzueto, Antonio, Brown, Nicola, Compton, Chris, Corbridge, Thomas C., Erb, David, Harvey, Catherine, Kaisermann, Morrys C., Kaye, Mitchell, Lipson, David A., Martin, Neil, Zhu, Chang-Qing, Papi, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149706/
https://www.ncbi.nlm.nih.gov/pubmed/34035312
http://dx.doi.org/10.1038/s41533-021-00241-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149706/
https://www.ncbi.nlm.nih.gov/pubmed/34035312
http://dx.doi.org/10.1038/s41533-021-00241-z

Ejemplares similares